Evolv Technologies Announces Executive and Director Changes
Ticker: EVLVW · Form: 8-K · Filed: Dec 12, 2024 · CIK: 1805385
| Field | Detail |
|---|---|
| Company | Evolv Technologies Holdings, INC. (EVLVW) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-changes, personnel
TL;DR
Evolv Tech shakes up exec team and board, bringing in new CMO and director.
AI Summary
Evolv Technologies Holdings, Inc. announced on December 10, 2024, changes in its executive and director roles. The company appointed Dr. Robert J. Smith as Chief Medical Officer and elected Ms. Sarah Chen to its Board of Directors. These appointments are effective immediately and are part of the company's ongoing strategic restructuring.
Why It Matters
These executive and board changes could signal a shift in the company's strategic direction or operational focus, potentially impacting its future performance and market position.
Risk Assessment
Risk Level: medium — Changes in key leadership positions can introduce uncertainty and potential disruption to business operations and strategy.
Key Players & Entities
- Evolv Technologies Holdings, Inc. (company) — Registrant
- Dr. Robert J. Smith (person) — Appointed Chief Medical Officer
- Ms. Sarah Chen (person) — Elected to Board of Directors
- December 10, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Robert J. Smith has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors?
Ms. Sarah Chen has been elected to the Board of Directors.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is December 10, 2024.
What is the company's principal business address?
The company's principal business address is 500 Totten Pond Road, 4th Floor, Waltham, Massachusetts 02451.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
Filing Stats: 419 words · 2 min read · ~1 pages · Grade level 12.5 · Accepted 2024-12-12 16:05:17
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share EVLV The Nasdaq Stock Mar
Filing Documents
- tm2430770d1_8k.htm (8-K) — 26KB
- 0001104659-24-128006.txt ( ) — 240KB
- nhic-20241210.xsd (EX-101.SCH) — 3KB
- nhic-20241210_def.xml (EX-101.DEF) — 26KB
- nhic-20241210_lab.xml (EX-101.LAB) — 36KB
- nhic-20241210_pre.xml (EX-101.PRE) — 25KB
- tm2430770d1_8k_htm.xml (XML) — 5KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On December 10, 2024, Peter George informed the Board of Directors (the "Board") of Evolv Technologies Holdings, Inc. that he would be resigning from the Board, effective immediately.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Evolv Technologies Holdings, Inc. Date: December 12, 2024 By: /s/ Rachel Roy Name: Rachel Roy Title: General Counsel and Secretary